loading

Perspective Therapeutics Inc Azioni (CATX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-07-01
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
3.46%
29.34
28.36 39.88 28.07 24.33
Depreciation and Amortization
1.33%
1.141
1.126 1.011 0.775 0.733
Operating Income/Loss
3.45%
-29.26
-28.28 -39.83 -27.86 -24.04
Nonoperating Income/Loss
8.75%
2.275
2.092 1.549 1.892 2.04
Income/Loss From Equity Method Investments
-0.001
- -0.001 - -
Income/Loss From Continuing Operations Before Tax
-26.98
- -38.28 -25.97 -21.48
Income Tax Expense/Benefit, Deferred
-
- - - -
Net Income/Loss
2.28%
-26.79
-26.19 -37.49 -25.97 -21.48
Basic Average Shares
16.45%
120.65
103.60 - 74.30 74.23
Diluted Average Shares
16.45%
120.65
103.60 - 74.30 74.23
Basic Earnings Per Share
12.00%
-0.22
-0.25 - -0.35 -0.29
Diluted Earnings Per Share
12.00%
-0.22
-0.25 - -0.35 -0.29
LAB LAB
$0.629
price down icon 4.47%
QSI QSI
$1.12
price down icon 14.50%
$3.87
price down icon 6.07%
$13.40
price down icon 3.74%
$27.42
price down icon 2.18%
$8.09
price down icon 2.65%
Capitalizzazione:     |  Volume (24 ore):